from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3122/-

LFCtreatmentdescriptionclass of inhibitor

0.344

Amikacinug/mL Amikacintranslation

0.447

Cap5-10ug/mL Capreomycintranslation

0.674

Rox10-50 ug/mL Roxithromycintranslation

-0.134

SM2-5 ug/mL Streptomycintranslation

1.120

Tet5-10 ug/mL Tetracyclinetranslation

0.488

Rif0.2-5ug/mL Rifampicintranscription

0.149

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.118

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.793

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.158

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.153

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.175

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.725

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.198

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.492

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.053

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.325

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.624

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.289

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.005

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.619

KCN5-20 ug/mL Potassium cyaniderespiration

-0.735

NaN30.2-2 mM Sodium aziderespiration

-0.483

Nigericin50 uM Nigericinrespiration

0.072

TRC10-150 ug/mL Triclosanrespiration

-1.213

TRZ10-25 ug/mL Thioridazinerespiration

0.360

Valinomycin0.5-10 uM Valinomycinrespiration

-2.282

ZnSO42 mM ZnSO4respiration

-0.709

menadione6-10 ug/mL Menadionerespiration

-0.443

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.082

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.271

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.585

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.237

NRP_1Non-replicating persistence stage 1dosRassociated

-0.024

Amp0.2mg/mL AmpicillincellWall

-0.051

Cephalexin20-100 ug/mL CephalexincellWall

-0.018

Cerulenin0.32-5 ug/mL CerulenincellWall

0.365

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.113

EMB10-20 ug/mL EthambutolcellWall

-0.302

Eta12-40 ug/mL EthionamidecellWall

-0.117

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.201

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.125

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.642

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.327

BZA0.12 mg/mL BenzamidearomaticAmides

0.911

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.130

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.933

H2O24 mM hydrogen peroxideDNAdamaging

-0.273

Levo10 ug/mL LevofloxacinDNAdamaging

0.276

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.018

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.046

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.382

UVUV-irradiationDNAdamaging

1.392

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.128

Antimycin12.5-50 ug/mL Antimycin A?

-0.131

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.328

PA_110-50 ug/mL Antitubercular compound PA-1?

0.082

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.542

PA8240.2-2 ug/mL PA-824?

-0.559

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.245

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.309

Verapamil50 uM Verapamil?

-1.028

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.214

methoxatin10-20 ug/mL Methoxatin?